BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 27730424)

  • 1. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
    van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
    Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
    van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
    Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast conserving therapy and mastectomy revisited: Breast cancer-specific survival and the influence of prognostic factors in 129,692 patients.
    Lagendijk M; van Maaren MC; Saadatmand S; Strobbe LJA; Poortmans PMP; Koppert LB; Tilanus-Linthorst MMA; Siesling S
    Int J Cancer; 2018 Jan; 142(1):165-175. PubMed ID: 28884470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast conserving therapy is associated with improved overall survival compared to mastectomy in early-stage, lymph node-negative breast cancer.
    Almahariq MF; Quinn TJ; Siddiqui Z; Jawad MS; Chen PY; Gustafson GS; Dilworth JT
    Radiother Oncol; 2020 Jan; 142():186-194. PubMed ID: 31615634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    Ann Surg Oncol; 2015 Nov; 22(12):3836-45. PubMed ID: 25743325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of local surgical treatment on survival in young women with T1 breast cancer: long-term results of a population-based cohort.
    Jeon YW; Choi JE; Park HK; Kim KS; Lee JY; Suh YJ
    Breast Cancer Res Treat; 2013 Apr; 138(2):475-84. PubMed ID: 23456232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-stage young breast cancer patients: impact of local treatment on survival.
    Bantema-Joppe EJ; de Munck L; Visser O; Willemse PH; Langendijk JA; Siesling S; Maduro JH
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e553-9. PubMed ID: 21601378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison.
    Ye JC; Yan W; Christos PJ; Nori D; Ravi A
    Clin Breast Cancer; 2015 Oct; 15(5):390-7. PubMed ID: 25957740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
    Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
    J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different statistical techniques dealing with confounding in observational research: measuring the effect of breast-conserving therapy and mastectomy on survival.
    van Maaren MC; le Cessie S; Strobbe LJA; Groothuis-Oudshoorn CGM; Poortmans PMP; Siesling S
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1485-1493. PubMed ID: 31020418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis.
    Thöne K; Rudolph A; Obi N; Chang-Claude J; Flesch-Janys D
    Breast Cancer Res Treat; 2018 Jul; 170(2):381-390. PubMed ID: 29556781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should women younger than 40 years of age with invasive breast cancer have a mastectomy? 15-year outcomes in a population-based cohort.
    Cao JQ; Truong PT; Olivotto IA; Olson R; Coulombe G; Keyes M; Weir L; Gelmon K; Bernstein V; Woods R; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):509-17. PubMed ID: 25194665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar survival with breast conservation therapy or mastectomy in the management of young women with early-stage breast cancer.
    Mahmood U; Morris C; Neuner G; Koshy M; Kesmodel S; Buras R; Chumsri S; Bao T; Tkaczuk K; Feigenberg S
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1387-93. PubMed ID: 22300561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
    Hartmann-Johnsen OJ; Kåresen R; Schlichting E; Nygård JF
    World J Surg Oncol; 2017 Jul; 15(1):118. PubMed ID: 28673296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.
    Walker GV; Smith GL; Perkins GH; Oh JL; Woodward W; Yu TK; Hunt KK; Hoffman K; Strom EA; Buchholz TA
    Cancer; 2010 Sep; 116(17):4000-6. PubMed ID: 20564117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locoregional recurrence and survival outcomes by type of local therapy and trastuzumab use among women with node-negative, HER2-positive breast cancer.
    Peterson DJ; Truong PT; Sadek BT; Alexander CS; Wiksyk B; Shenouda M; Raad RA; Taghian AG
    Ann Surg Oncol; 2014 Oct; 21(11):3490-6. PubMed ID: 24841346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
    Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
    Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are breast conservation and mastectomy equally effective in the treatment of young women with early breast cancer? Long-term results of a population-based cohort of 1,451 patients aged ≤ 40 years.
    van der Sangen MJ; van de Wiel FM; Poortmans PM; Tjan-Heijnen VC; Nieuwenhuijzen GA; Roumen RM; Ernst MF; Tutein Nolthenius-Puylaert MC; Voogd AC
    Breast Cancer Res Treat; 2011 May; 127(1):207-15. PubMed ID: 20703938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.
    Agarwal S; Pappas L; Neumayer L; Kokeny K; Agarwal J
    JAMA Surg; 2014 Mar; 149(3):267-74. PubMed ID: 24429935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Yu TJ; Liu YY; Hu X; Di GH
    Eur J Surg Oncol; 2018 Nov; 44(11):1703-1707. PubMed ID: 30029824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.